UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003650 |
|---|---|
| Receipt number | R000004419 |
| Scientific Title | Phase II study of gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced biliary tract cancer (JASPAC02) |
| Date of disclosure of the study information | 2010/05/21 |
| Last modified on | 2013/11/23 13:28:25 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/05/21 13:43:49 | ||
| 2 | Update | 2010/12/13 13:35:15 | Last name of lead principal investigator Last name of lead principal investigator Institutions |
|
| 3 | Update | 2011/11/04 15:31:22 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 4 | Update | 2011/12/21 20:42:44 | Recruitment status Last follow-up date |
|
| 5 | Update | 2013/11/23 13:28:25 | Recruitment status Publication of results URL related to results and publications |
